Faculty who have authored publication Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study.
Name | Title | Department | Institution |
---|---|---|---|
Parameswaran Hari MD | Adjunct Professor | Medicine | Medical College of Wisconsin |